[Selective intraarterial application of Thienam and Vasoprostan in the treatment of purulent foot diseases in patients with diabetes mellitus].
Antsypovich
E A
EA
Molchanov
V F
VF
Kadyshev
Iu G
IuG
Brusnitsyna
M A
MA
D000038:Abscess / Q000473:pathology; D015377:Cilastatin / Q000627:therapeutic use; D000077728:Cilastatin, Imipenem Drug Combination; D048909:Diabetes Complications; D017719:Diabetic Foot / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D004338:Drug Combinations; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D008866:Microsurgery; D014665:Vasodilator Agents / Q000627:therapeutic use*
D004338:Drug Combinations; D014665:Vasodilator Agents; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination
Selektivnoe vnutriarterial'noe primenenie tienama v vazoprostana pri lechenii gnoĭnykh zabolevaniĭ stopy u bol'nykh sakharnym diabetom.